Today, we reintroduced a first-of-its-kind therapeutic approach that provides an alternative to standard of care eye injections for wet age-related macular degeneration, a leading cause of blindness for people aged 60 and over in the U.S. This evolution of the Port Delivery Platform lays the foundation for future retinal advancements. Read the full announcement here: http://spr.ly/60449Y8DE
Congratulations on reintroducing Susvimo! Interesting read.
Great news!
Congratulations, Chin-Wei Soo, FRAPS!!
Exciting times!
Congratulations!
Congrats Chin!
Congratulations! It’s back!!!